The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

Recent study links blood proteins to aggressive prostate cancer, identifying potential biomarkers for early risk prediction ...

Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes ...

Prostate cancer is the most common cancer in men – in 2013, it affected more than one million men across the world.

A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.

Thousands of men with high-risk prostate cancer could soon live longer, thanks to a  test that helps doctors identify which ...

Dr. Roach weighs in on whether a patient should proceed with a prostate biopsy after conflicting test results.

A Johns Hopkins study of 192 patients shows two FDA-cleared capillary blood collection devices reliably measure NfL, GFAP and ...

IF GETTING A screening test for prostate cancer isn’t on your radar, it’s probably because the government guidelines ...

Bruce Arians shared his prostate cancer survival story during the NFL's "Crucial Catch" week, urging men to get a simple PSA blood test every year.

For a man who has been putting off a prostate check because he fears “the finger”, there is something worth knowing: prostate cancer screening can begin with a blood test. You do not have to agree to ...